Medifast Q2 FY26 net loss widens to $3.1 million; revenue drops 27.6% to $76.4 million - MED News | RalliesMedifast Q2 FY26 net loss widens to $3.1 million; revenue drops 27.6% to $76.4 million
M
MED• Quarterly results
- Medifast posted Q2 2026 revenue of USD 76.4 million, down 27.6% year over year.
- Net results turned to a loss of USD 3.1 million, or USD 0.28 per diluted share.
- Active earning coaches fell 48.7% to 11,700, while revenue per active earning coach rose 41% to USD 6,529.
- Cash, cash equivalents and investment securities totaled USD 169.8 million at June 30, with no debt.
- Forecasts Q3 revenue of USD 60 million to USD 80 million, with loss per share of USD 0.15 to USD 0.65.
•
